ASX AnnouncementsRetirement of Non-Executive Director14 Sep at 4:47 pm0Patrys has today announced the retirement of Ms Suzy Jones as a Director of Patrys effective from close of business…
ASX AnnouncementsPatrys FY23 Annual Report28 Aug at 4:47 pm0Patrys has today released its Annual Report for the 2022-23 Financial Year (FY23). Highlights include: Successful completion of the PAT-DX1…
ASX AnnouncementsQuarterly Activities Report and 4C | 30 June 202326 Jul at 10:04 am0Patrys has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 30…
MediaPatrys featured as one of Top 10 Best Healthcare Companies in Australia13 Jul at 12:19 pm0Patrys has been featured as one of the Top 10 Best Healthcare Companies in Australia in Insights Care Magazine. CEO and MD,…
Market AnnouncementDraft GLP toxicology reports received24 May at 10:56 am0Patrys today announced that it has received positive draft reports for two recently completed Good Laboratory Practice (GLP) toxicology studies…
ASX AnnouncementsQUARTERLY ACTIVITIES REPORT & 4C | 31 March 202324 Apr at 10:51 am0Patrys has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 31…
MediaVideoVIDEO | Proactive17 Apr at 11:08 am0Patrys’ CEO and MD, Dr James Campbell, spoke with Proactive’s Elisha Newell about the announcement of two new US patents for the Company’s…
ASX AnnouncementsTwo New Patents Granted by US Patent and Trademark Organisation17 Apr at 9:34 am0Patrys’ deoxymab platform has been further strengthened by the granting of two new patents by the US Patent and Trademark…
ASX AnnouncementsUpdated guidance for PAT-DX1 phase 1 clinical study31 Mar at 8:56 am0Patrys Limited (ASX: PAB), has advised that, based on recent updates from its Contract Development Manufacturing Organisation (CDMO) regarding the…
ASX AnnouncementsPreclinical data supports synthetic lethality application14 Mar at 10:44 am0A new preclinical study exploiting the novel ability of deoxymabs to enter the cell nucleus to disrupt the cell’s DNA…